Showing results (61-70 of 119) with videos related to

Sort By:
Pageof 12
Cancer Science|October 20, 2023
Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practiceIppei Fukada, Seiichi Mori, Naomi Hayashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2018
Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor-Engineered T Cells for Ovarian CancerTatsuo Matsuda, Matthias Leisegang, Jae-Hyun Park, et al.
Cancer Science|December 25, 2018
Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutationsEisaku Miyauchi, Tatsuo Matsuda, Kazuma Kiyotani, et al.
Carcinogenesis|August 17, 2004
Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokersMasaki Fujieda, Hiroshi Yamazaki, Tetsuya Saito, et al.
Cancer Immunology Research|December 14, 2019
Impact of TCR Diversity on the Development of Transplanted or Chemically Induced TumorsKarin Schreiber, Theodore G Karrison, Steven P Wolf, et al.
International Journal of Clinical Oncology|April 26, 2024
Availability of genome-matched therapy based on clinical practiceNaomi Hayashi, Seiichi Mori, Akihiro Ohmoto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 23, 2009
Two novel CYP2D6*10 haplotypes as possible causes of a poor metabolic phenotype in JapaneseMasayuki Matsunaga, Hiroshi Yamazaki, Kazuma Kiyotani, et al.
Molecular Cancer Research : MCR|October 5, 2014
WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neckVassiliki Saloura, Hyun-Soo Cho, Kazuma Kiyotani, et al.
Scientific Reports|January 20, 2017
WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancerVassiliki Saloura, Theodore Vougiouklakis, Makda Zewde, et al.
Science Immunology|September 13, 2024
CD4+ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapySteven P Wolf, Matthias Leisegang, Madeline Steiner, et al.
Pageof 12